Su contribución hace posible que nuestra organización sin fines de lucro continúe providing
Ascendis Pharma is applying its innovative platform technology to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients’ lives. Guided by its core values of patients, science and passion, the company utilizes its TransCon™ technologies to create new and potentially best-in-class therapies. Ascendis Pharma currently has a pipeline of three independent endocrinology rare disease product candidates in clinical development and is advancing oncology as its second therapeutic area of focus. The company continues to expand into additional therapeutic areas to address unmet patient needs.
Ascendis is headquartered in Copenhagen, Denmark, with additional offices in Heidelberg and Berlin, Germany, and in Palo Alto and Redwood City, California.
​
For more information, please visit www.ascendispharma.com.
​
Or, email Ascendis Pharma, Inc. at medicalinformation@ascendispharma.com
Novo Nordisk is a global healthcare company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for 95 years. This heritage has given us experience and capabilities that also enable us to help people defeat other serious diseases including obesity, hemophilia and growth disorders.
We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term and do business in a financially, socially and environmentally responsible way. With U.S. headquarters in New Jersey and production and research facilities in six states, Novo Nordisk employs nearly 6,000 people throughout the country.
For more information, visit novonordisk.us, Facebook, Instagram and Twitter.
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases.
The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com.
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across our Allergan Aesthetics portfolio. For additional information, please visit www.abbvie.com.
Endo is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them. Learn more at www.endo.com.
Sala de exposiciones virtuales www.Pfizer.com.
Ascendis Pharma está aplicando su tecnologÃa de plataforma innovadora para construir una empresa biofarmacéutica lÃder y totalmente integrada centrada en marcar una diferencia significativa en la vida de los pacientes. Guiada por sus valores centrales de pacientes, ciencia y pasión, la compañÃa utiliza sus tecnologÃas TransConâ„¢ para crear terapias nuevas y potencialmente las mejores en su clase. Ascendis Pharma actualmente tiene una cartera de tres candidatos independientes de productos de enfermedades raras de endocrinologÃa en desarrollo clÃnico y está avanzando en la oncologÃa como su segunda área terapéutica de enfoque. La compañÃa continúa expandiéndose hacia áreas terapéuticas adicionales para abordar las necesidades no satisfechas de los pacientes.
Ascendis tiene su sede en Copenhague, Dinamarca, con oficinas adicionales en Heidelberg y BerlÃn, Alemania, y en Palo Alto y Redwood City, California.
​
For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.
